VetClick
Menu Menu
Login

VetClick

/ News
Friday, 19th April 2024 | 4,364 veterinary jobs online | 118 people actively seeking work | 5,484 practices registered

Veterinary Industry News

Send us your news
New Bovigen Scour from Virbac

New Bovigen Scour from Virbac

New Bovigen Scour From Virbac Helps To Reduce Diarrhoea In Calves

8 years ago
3626 views

Posted
10th February, 2016 10h07

Author
Virbac Animal Health


Virbac has extended its Large Animal vaccine range with the launch of Bovigen Scour®, an emulsion for injection into cattle which reduces the severity of diarrhoea caused by bovine rotavirus, bovine coronavirus and enteropathogenic E.coli F5 (K99).  Bovigen Scour works by actively immunising pregnant cows and heifers and providing passive immunity to their calves via colostrum.  The vaccine also helps to reduce the shedding of virus by calves infected with bovine rotavirus and coronavirus.

 According to Virbac, a key benefit of Bovigen Scour is the vaccination protocol which offers a large window for injection, making it easier for vaccination planning.   The primary course is administered in two shots with first dose between 12 and 5 weeks before calving with the booster 3 weeks later.  The annual booster is then due between 12 and 3 weeks before calving is expected.

The vaccine is presented in convenient packaging in two sizes: 15ml (5 doses) and 90ml (30 doses).  The dosage per cow is 3 ml and the withdrawal time is nil in milk.

Virbac Large Animal Product Manager Brigitte Goasduf MRCVS said:  "Bovigen Scour offers farmers flexibility and ease of use.  The flexibility it gives in terms of scheduling the primary course and booster is particularly important and is highly relevant for beef cattle farmers as it can be difficult to know exactly when a cow is likely to calve and it is vital not to miss the vaccination window.    

"Bovigen Scour is also convenient to give because of the small volume of emulsion and because the injection is given intramuscularly.  Its launch extends our Large Animal vaccine range, which includes Gudair®,  for the active immunisation of sheep and goats against Mycobacterium avium subspecies paratuberculosis (Map).  We are delighted to add it to our growing Large Animal portfolio."

An independent veterinary pharmaceutical company, Virbac's investment in R&D is focused on promoting animal welfare and offering veterinary surgeons and farmers innovative solutions and treatment approaches, such as the recent launch of the award-winning* FARMPACK and FLEXIBAG dispensing system for its pour-on range, Deltanil and Neoprinil. It aims to work in close partnership with its customers, providing the advice and support they need to run successful, profitable businesses.

For further information:
Rebecca George
George PR

Tel: 01449 737281/07974 161108


More from Virbac Animal Health


You might be interested in...